An AI-driven platform connecting cancer patients to bio-pharmaceutical clinical trials.
Targeted cancer therapies • Cancer genomics • Tumor profiling technologies • Clinical trial selection • Second Opinion
51 - 200
💰 $16.5M Series B on 2022-12
February 27
An AI-driven platform connecting cancer patients to bio-pharmaceutical clinical trials.
Targeted cancer therapies • Cancer genomics • Tumor profiling technologies • Clinical trial selection • Second Opinion
51 - 200
💰 $16.5M Series B on 2022-12
• Provide access to clinical trials for every cancer patient using technology at a global scale • Proprietary patient recruitment and enrollment enablement solution for oncology clinical trials • Part of the $18 billion pharma clinical trial enablement market with double digit annual growth • Tech enabled services and big data platform addressing clinical trial enrollment friction points • Headquartered in NYC with a team of 70 people • Founded by ex-PE, clinical and technology executives
• 3+ yrs experience in (data driven) channel partnership development in consumer tech, healthcare tech, or healthcare ecosystem • Exceptional relationship-building skills • Start-up mindset • Exceptional written and communication skills • Proactive, passionate, detail-oriented, data-driven, growth mindset • B.A. or B.S. degree in Business, Economics or equivalent experience
• Equal employment opportunities • Prohibition of discrimination and harassment • Comprehensive policy covering all terms and conditions of employment
Apply NowFebruary 22
51 - 200
🇺🇸 United States – Remote
💰 Venture Round on 2022-03
⏰ Full Time
🔴 Lead
🏆 Customer Success + Account Manager
February 22
1001 - 5000
February 15
11 - 50
🇺🇸 United States – Remote
💰 $25M Series B on 2022-02
⏰ Full Time
🔴 Lead
🏆 Customer Success + Account Manager
February 14
51 - 200
February 12
11 - 50
🇺🇸 United States – Remote
💰 Seed Round on 2019-03
⏰ Full Time
🔴 Lead
🏆 Customer Success + Account Manager